Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study

(2020) Helene Moustgaard et al.   BMJ-British Medical Journal

Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews

(2020) Livia Puljak et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application

(2020) Silvia Minozzi et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Allocation Concealment and Intention-To-Treat Analysis Do Not Influence the Treatment Effects of Physical Therapy Interventions in Low Back Pain Trials: a Meta-epidemiologic Study

(2019) Matheus Oliveira de Almeida et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

(2019) Huseyin Naci et al.   BMJ-British Medical Journal

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Biases in Randomized Trials

(2017) Mohammad Ali Mansournia et al.   EPIDEMIOLOGY

What is the influence of randomisation sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological study

(2015) Susan Armijo-Olivo et al.   BMJ Open

Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach

(2012) Stephen Wright et al.   Trials

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY